Merck & Co’s $394 million acquisition of Viralytics has stoked interest in oncolytic viruses, a class of drugs that have been in the shadow of the checkpoint inhibitors and CAR-T therapies that ...

PsiVac is set to end decades of disappointing data on oncolytic viruses with a radical new approach that upends conventional wisdom about the modality. Rather than engineer the viral genome ...

It's not the first therapy in the oncolytic virus class to be approved around the world, as that accolade went to Amgen's Imlygic (talimogene laherparepvec), which was cleared by the FDA for the ...

While working on oncolytic viruses at the University of Helsinki, Akseli Hemminki, professor of oncology, and his team took advantage of the European Advanced Therapy Access Directive to treat ...

Intravenous; NDV: Newcastle disease virus; OS: Overall survival ... Other proteins such as H-Ras and Rac1 have been shown to mediate oncolytic specificity in certain systems.

This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into this transformative approach to cancer treatment. Oncolytic virus ...